Clinical Trials Logo

Clinical Trial Summary

The investigators wish to perform a pilot study at the Manitoba Men's Health Clinic to assess if pre-vasectomy counseling with ChatGPT can safely streamline the consultation process by reducing visit times, while increasing patient satisfaction with the consultation process.


Clinical Trial Description

The release of ChatGPT, a natural language AI chat bot, has recently captured the attention of the general public and medical professionals world-wide. ChatGPT is a conversational AI language model designed by OpenAI that utilizes deep learning techniques to generate human like responses to questions. There has been increasing interest among the medical community on developing new ways to harness this technology to aid medical professionals. New applications have included writing scientific manuscripts, drafting correspondents, as well as testing its ability on standardized medical licensing examinations. ChatGPT was able to perform at or near passing threshold on the United States Medical Licensing Exam (USMLE). Despite ChatGPT demonstrating good medical knowledge, it is still unclear if this translates to real world clinical practice. Physician burnout is becoming an increasing problem. Per a recent Canadian Urologic Association (CUA) census, burnout was identified in 39% of urologists, with high number of patient visits/week to be cited as a predictor predictive of burnout. That begs the question, can ChatGPT be used for patient counseling and to improve patient flow in one's practice? ChatGPT has been shown to provide effective and safe responses to medical questions and even "curbside" consultations. However its ability to counsel patients in real time has not yet been studied. As such, the investigators wish to perform a pilot study at the Manitoba Men's Health Clinic to assess if pre-vasectomy counseling with ChatGPT can safely streamline the consultation process by reducing visit times, while increasing patient satisfaction with the consultation process. If the hypothesis provides true, further implementation of ChatGPT in a healthcare practice may work to reduce the burden on health care providers. There are no predicted adverse events of this study. There are no identified potential harms of this study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06009783
Study type Interventional
Source University of Manitoba
Contact Premal Patel, MD
Phone 204-221-4476
Email ppatel5@hsc.mb.ca
Status Recruiting
Phase N/A
Start date August 30, 2023
Completion date October 5, 2023

See also
  Status Clinical Trial Phase
Completed NCT02577601 - Impact of Combined Hormonal Contraceptives on UPA Phase 4
Completed NCT03153644 - Improving Contraceptive Care for Women With Medical Conditions
Completed NCT04112095 - Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use Phase 3
Recruiting NCT05521646 - Implementing Best Practice Postpartum Contraceptive Services Through a Quality Improvement Initiative N/A
Active, not recruiting NCT04291001 - Ovarian Function With ENG Implant and UPA Use Early Phase 1
Completed NCT04568980 - Assessment of Contraceptive Safety and Effectiveness in Cystic Fibrosis
Completed NCT03438682 - Real World Effectiveness and Safety of Hysteroscopic (Essure®) Compared to Laparoscopic Sterilization
Active, not recruiting NCT01948882 - Evaluation of Safety and Effectiveness of the Essure (Model ESS505) Device to Prevent Pregnancy in Women N/A
Enrolling by invitation NCT04997499 - Adolescent Subcutaneous (SQ) Injection Video Validation N/A
Recruiting NCT03589040 - Darunavir and Rilpivirine Interactions With Etonogestrel Contraceptive Implant Phase 2
Completed NCT04463680 - Rifampin and the Contraceptive Implant Phase 4
Completed NCT03154125 - Sayana® Press Extension Study Phase 3
Withdrawn NCT03725358 - A Cluster-RCT to Increase the Uptake of LARCs Among Adolescent Females and Young Women in Cameroon. N/A
Completed NCT02957630 - "E4/DRSP Endocrine Function, Metabolic Control and Hemostasis Study" Phase 1/Phase 2
Completed NCT02456584 - Pharmacodynamics and Pharmacokinetics Study of Existing DMPA Contraceptive Methods Phase 1
Completed NCT02718222 - Impact and Performance of Institutionalizing Immediate Post-partum IUD Services N/A
Recruiting NCT02121067 - LNG-IUS at 2 Weeks Postpartum Phase 4
Terminated NCT02169869 - Immediate Postplacental IUD Insertion N/A
Recruiting NCT02292056 - Medication Safety and Contraceptive Counseling for Reproductive Aged Women With Psychiatric Conditions N/A
Withdrawn NCT01930994 - Kenya Sino-implant (II) PK Study N/A